Benitec Biopharma Inc.: Benitec Biopharma Releases Second Quarter 2023 Financial Results and Provides Operational Update
HAYWARD, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "Company"), a development-stage, gene therapy-focused, biotechnology company developing novel genetic
United States William Windham Clinical Development Program Overview Benitec Or Company Benitec Biopharma Inc Solebury Strategic Communications
Source: finanznachrichten.de